Plexus Corp.

Informe acción NasdaqGS:PLXS

Capitalización de mercado: US$7.3b

Plexus Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Plexus ha aumentado sus beneficios a una tasa media anual de 3.6%, mientras que los beneficios de la industria de Electronic han experimentado un crecimiento de 3.8% anual. Los ingresos han ido creciendo a una tasa media de 4% al año. La rentabilidad financiera de Plexus es de 12.6%, y sus márgenes netos son de 4.4%.

Información clave

3.58%

Tasa de crecimiento de los beneficios

5.01%

Tasa de crecimiento del BPA

Crecimiento de la industria Electronic 15.34%
Tasa de crecimiento de los ingresos3.96%
Rentabilidad financiera12.59%
Margen neto4.35%
Última actualización de beneficios04 Apr 2026

Actualizaciones de resultados anteriores recientes

Recent updates

Nueva narrativa May 04

Semicap And Aerospace Slowdowns Will Pressure Margins And Constrain Future Cash Generation

Catalysts About Plexus Plexus provides design, engineering and manufacturing services for complex electronic products across aerospace and defense, healthcare, industrial and other end markets. What are the underlying business or industry changes driving this perspective?
Actualización de narrativa Apr 25

PLXS: Higher P/E And Rich Multiple Will Likely Cap Future Upside

Plexus' analyst fair value estimate has been adjusted from $200.80 to $210.80 as analysts factor in updated assumptions on growth, margins and future P/E, supported by a series of recent target increases and an upgrade from major research firms. Analyst Commentary Recent Street research on Plexus focuses on refreshed targets and an upgrade, which analysts link to their updated assumptions on growth, margins and the P/E they are willing to apply to the stock.
Actualización de narrativa Apr 10

PLXS: Higher P/E Assumptions Will Likely Limit Upside Despite Buybacks

Analysts have raised their price targets on Plexus from $25 to $50, citing updated assumptions around discount rates and future P/E ratios that support a refined view of the stock's valuation. Analyst Commentary Recent research updates on Plexus focus heavily on how revised discount rates and updated P/E assumptions shape the new price targets.
Actualización de narrativa Mar 27

PLXS: Raised Price Views And Buybacks Will Likely Support Balanced Trading Outlook

Analysts have raised their Plexus price targets by $25 to $50, pointing to modestly adjusted assumptions for growth, margins, and future P/E to support their higher valuation views. Analyst Commentary Recent research points to a cluster of higher Plexus price targets in the US$25 to US$50 range above prior levels, reflecting tweaked assumptions around growth, margins, and the P/E multiple investors might be willing to pay.
Actualización de narrativa Mar 12

PLXS: Updated Earnings Views And Buybacks Will Likely Support Balanced Trading Outlook

Analysts have raised their average Plexus price target by a combined $105. This reflects updated assumptions on discount rates, revenue growth, profit margins and future P/E multiples.
Actualización de narrativa Feb 26

PLXS: Higher Earnings Assumptions And Buybacks May Sustain Sideways Trading

Narrative Update on Plexus The analysts’ average price target for Plexus has increased by a combined $105 in recent reports, reflecting updated assumptions for discount rates, revenue growth, profit margins, and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Plexus centers on higher price targets, with analysts updating their models around discount rates, revenue expectations, margin assumptions, and a slightly lower future P/E multiple.
Actualización de narrativa Feb 09

PLXS: Higher Earnings Assumptions May Support Sideways Trading Near Current Range

The analyst price target for Plexus has shifted from US$159 to about US$201, as analysts factor in updated views on revenue growth, profit margins, and the P/E multiple they are comfortable assigning to the stock. Analyst Commentary Bullish analysts have increased their price targets in several steps, including US$25, US$30, and US$50 adjustments, which lines up with the higher overall target of about US$201.
Nueva narrativa Jan 31

Aerospace And Defense Outsourcing Wave Will Support Stronger Long Term Outlook

Catalysts About Plexus Plexus provides outsourced design, engineering and manufacturing solutions for complex products across Healthcare, Industrial and Aerospace and Defense end markets. What are the underlying business or industry changes driving this perspective?
Actualización de narrativa Jan 26

PLXS: Manufacturing Partnership And Stable Outlook Will Likely Support Sideways Trading

Analysts have maintained their Plexus fair value estimate at $159.00. The updated assumptions reflect slightly adjusted revenue growth, revised profit margin expectations, and a marginally higher future P/E multiple as they refine their price target framework.
Actualización de narrativa Jan 12

PLXS: Robust Finish And New Partnership Will Likely Support Sideways Trading

Analysts have raised their Plexus price target to $150 from $140, citing solid recent results and consistent execution. They also noted a more cautious stance on longer term estimates given the current macro backdrop.
Artículo de análisis Dec 30

Is It Too Late To Consider Buying Plexus Corp. (NASDAQ:PLXS)?

Plexus Corp. ( NASDAQ:PLXS ), is not the largest company out there, but it saw a double-digit share price rise of over...
Actualización de narrativa Dec 24

PLXS: Shares Will Likely Trade Sideways As Robust Finish Meets Rich Pricing

Analysts have nudged their Plexus price target higher to $150 from $140, citing a robust fiscal year finish that beat sales and earnings expectations while still acknowledging valuation and macroeconomic uncertainties. Analyst Commentary Street research on Plexus reflects a mix of optimism around recent execution and caution regarding valuation and the macro backdrop, leading to a more balanced risk reward profile at current levels.
Actualización de narrativa Dec 10

PLXS: Shares Will Likely Trade Steadily As Execution Offsets Macro Caution

Analysts have modestly increased their Plexus price target to approximately $159 per share. This reflects confidence in the company’s robust execution and long term growth prospects, despite a more cautious stance on the macro environment and valuation.
Actualización de narrativa Nov 26

PLXS: Shares Will Likely Climb With Confidence In Earnings Momentum

Analysts have modestly increased Plexus’s average price target, citing robust recent results, a positive management outlook, and continued confidence in the company’s growth prospects, with new targets ranging up to $165 from previous levels around $140 to $160. Analyst Commentary Following the latest quarterly report, analysts have provided updated perspectives on Plexus, balancing improved outlooks with some caution regarding future risks.
Actualización de narrativa Nov 09

PLXS: Shares Will Likely Reflect Mixed Views As Macro Uncertainty Persists

Analysts have slightly raised their price targets for Plexus, citing strong recent results and ongoing confidence in the company's growth prospects. The new targets range from $150 to $165, which is an increase of $10 to $5 from previous estimates.
Actualización de narrativa Oct 26

Execution On Expansion Plans Will Shape Near-Term Manufacturing Opportunities

The analyst consensus price target for Plexus has increased by $4.40 to $159.00. This reflects upward revisions in revenue growth expectations and ongoing confidence in management’s execution, even as some firms have issued cautious outlooks recently.
Seeking Alpha Sep 11

Plexus: Pipeline Underscores The Growth Potential Amid Short-Term Headwinds

Summary Plexus delivers steady execution and stable margins, but faces uneven growth and slower program ramps compared to AI-focused peers. Revenue and earnings growth are projected to be modest, with recovery in industrial and healthcare end markets critical for upside. Valuation remains reasonable, trading near historical P/E, but lacks catalysts to drive a bullish re-rating in the near term. With limited near-term upside and risks from slow program execution, I maintain a neutral stance on Plexus shares. Read the full article on Seeking Alpha
Artículo de análisis Sep 11

Return Trends At Plexus (NASDAQ:PLXS) Aren't Appealing

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Artículo de análisis Jun 24

Why Investors Shouldn't Be Surprised By Plexus Corp.'s (NASDAQ:PLXS) P/E

Plexus Corp.'s ( NASDAQ:PLXS ) price-to-earnings (or "P/E") ratio of 25.4x might make it look like a sell right now...
Seeking Alpha Sep 16

Plexus Is Overvalued Despite Its Unique Position In Manufacturing

Summary Plexus has a distinct position in the manufacturing market for low-to-mid volume in specialized industries with high regulatory requirements, like healthcare and defense. This provides somewhat of a moat. Despite this strength, the stock is currently overvalued based on my peer and company-specific historical valuation analysis. I expect its P/E non-GAAP ratio will contract. In an optimistic scenario, there is the potential for a 12-month return of 20%+. However, this depends on EPS up revisions continuing and a moderate contraction in its P/E ratio. Even in the event of a strong 12-month return, the long-term thesis is weaker due to lower fundamental growth estimates for FY26 against FY25. Read the full article on Seeking Alpha
User avatar
Nueva narrativa Sep 04

Aerospace And Healthcare Drive Growth Amid Rising Efficiency And Responsible Practices

Expected revenue growth driven by strong demand in Aerospace, Healthcare/Life Sciences, and semiconductor sectors, enhancing future earnings.

Desglose de ingresos y gastos

Cómo gana y gasta dinero Plexus. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqGS:PLXS Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
04 Apr 264,3101882110
03 Jan 264,1271772020
27 Sep 254,0331732000
28 Jun 254,0251632020
29 Mar 253,9681432020
28 Dec 243,9541201970
28 Sep 243,9611121900
29 Jun 243,9341111800
30 Mar 243,9951021730
30 Dec 234,0991261750
30 Sep 234,2101391760
01 Jul 234,3101491770
01 Apr 234,2701711790
31 Dec 224,0881571730
01 Oct 223,8111381670
02 Jul 223,5311211590
02 Apr 223,3641111510
01 Jan 223,3561261490
02 Oct 213,3691391440
03 Jul 213,4391431460
03 Apr 213,4821521470
02 Jan 213,3681231460
03 Oct 203,3901171530
04 Jul 203,2871171530
04 Apr 203,2301061530
04 Jan 203,2511171520
28 Sep 193,1641091480
29 Jun 193,1251451460
30 Mar 193,0521461440
29 Dec 182,9621341430
29 Sep 182,874131400
30 Jun 182,772-311330
31 Mar 182,665-321300
30 Dec 172,570-151250
30 Sep 172,5281121260
01 Jul 172,5111021240
01 Apr 172,5601031220
31 Dec 162,574901190
01 Oct 162,556761150
02 Jul 162,572811150
02 Apr 162,574791160
02 Jan 162,606861180
03 Oct 152,654941220
04 Jul 152,652971220

Ingresos de calidad: PLXS tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (4.4%) de PLXS son superiores a los del año pasado (3.6%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de PLXS han crecido un 3.6% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de PLXS en el último año (30.2%) supera su media de 5 años (3.6% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de PLXS en el último año (30.2%) superó al de la industria Electronic 13.4%.


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de PLXS (12.6%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/27 19:14
Precio de las acciones al final del día2026/05/27 00:00
Beneficios2026/04/04
Ingresos anuales2025/09/27

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Plexus Corp. está cubierta por 15 analistas. 5 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Reik ReadBaird
Wamsi MohanBofA Global Research
Andrew HuangB. Riley Securities, Inc.